GLUE Monte Rosa Therapeutics, Inc.
Healthcare$18.96+0.00%OpenMarket Cap: $1.23B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$31.75
Target (Median)
$34.00
Target Range
$22.00 - $37.00
Upside from current price: 67.4%
Rating Distribution
2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-18 | Guggenheim | maintain | Buy | Buy |
| 2026-03-18 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-01-14 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-08 | Guggenheim | maintain | Buy | Buy |
| 2026-01-08 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-07 | Wells Fargo | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-1.84 | $58.2M | 5 |
| Sun Dec 31 | $-2.29 | $22.3M | 5 |
| Mon Dec 31 | $-2.11 | $115.1M | 1 |
| Tue Dec 31 | $-1.58 | $173.9M | 1 |